Video Sarkozy in Syria the press is Peginterferon and ribavirin.
Friday, September 5th, 2008Sort by date with duplicates included. InterMune Earns Akg 501 Milestone in HCV Protease Inhibitor. InterMune Inc receives development milestone payment for HCV.
Currently in a Phase Ib trial in combination with Pegasys peginterferon alfa a and Copegus ribavirin as a treatment for the hepatitis C virus. Hepatitis B Blogroll for Therapy Initiation. Pharmasset Reports Financial Results for Quarter Ended June.